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Black and Minority Ethnic women’s decision-making for risk reduction strategies after BRCA 
testing: use of context and knowledge 
 
 Abstract 
Within the field of breast cancer care, women concerned about their family history are 
offered genetic testing and subsequent treatment options based on several factors which include 
but are not limited to personal and family cancer disease histories and clinical guidelines. 
Discussions around decision-making in genetics in Black and Minority Ethnic (BME) groups are rarely 
documented in literature, and information regarding interactions with genetics services is usually 
discussed and linked to lack of scientific knowledge. As such, counselling sessions based only on 
scientific and medical information miss out the many reasons participants consider in making health 
decisions, information which can be used to encourage BME women to engage in cancer genetics 
services. 10 BME women with a mixed personal and family history of breast and ovarian cancer 
backgrounds, were interviewed in a study exploring issues of knowledge about familial breast cancer 
syndromes, to understand how they created and used familial knowledge for health decisions, with 
a particular focus on attitudes towards risk reducing strategies. 
 
Study results show that our participants are not unique in the ways they make decisions 
towards the use of cancer genetics and risk reduction strategies and  as such, there are no specific 
ethnically defined pathways for decision-making. Our participants demonstrated mixed biomedical, 
social and individual cultural reasons for their decision-making towards risk reduction surgeries and 
treatment options which are similar to women from different ethnicities and are individual rather 
than group-specific. Narratives about suspicion of scientific utility of genetic knowledge, the 
perceived predictive value of mutations for future cancers or the origin of mutations and family 
disease patterns feature heavily in how participants evaluated genetic information and treatment 
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decisions. The diversity of results shows that our participants are interested in engaging with genetic 
information but use multiple sources for evaluating the extent of involvement in genetic services 
and the place of genetic information and treatment options for themselves and their families. 
Genetic information is considered within various bio-social scenarios before decision-making for risk 
reduction is undertaken. BME women are shown to undertake evaluative processes which clinicians 
are encouraged to explore for better patient support. Continuing to focus on links between 
superficial and un-representative meanings of ethnicity, ethnic identity and attitudes and behaviours 
by only searching for differences between ethnic groups, are unhelpful in further understanding how 
women from those diverse backgrounds make decisions towards risk reduction interventions. Future 
research must find ways of investigating and understanding populations in ways that are not 
focussed solely on ethnic differences but on how meaning is created out of social circumstances and 
experiences.     
 
Background 
The advance of medical knowledge and technology within the field of cancer has led to new 
ways of knowing, understanding, treating and interacting with the disease. Although a multi-factorial 
disease, there is increased understanding of the genetic basis of cancer, and genetic variation has 
been identified which increases the likelihood of developing certain types of cancers. For example  
mutations in the BRCA1/2 genes, increase one’s likelihood of developing breast, ovarian, prostate 
and pancreatic cancers (Wiesmuller, 2011). Identifying those who are likely to be affected by, or 
carry these gene mutations, is undertaken in various ways, including assessing individuals’ personal 
and family cancer disease histories and conducting genetic testing. Once those at increased risk of 
developing cancer are identified, several clinical interventions to reduce that risk are offered 
(National Cancer Institute, 2015; National Institute for Health and Care Excellence, 2013; USA Food 
and Drug Administration, 2017) dependent upon age, other relevant biological information and care 
systems (Gadzicki et al., 2011; Leonarczyk and Mawn, 2015).  
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In the UK (National Institute for Health and Care Excellence, 2013), some of the 
interventions that patients could be offered include medical and surgical interventions such as 
chemoprevention medication, mastectomy and oophorectomy, as well as to which degrees the 
surgical interventions will be carried out (Godet and M. Gilkes, 2017). These interventions bring 
several issues of concern; for example efficacy, physical side effects, social and psychological impacts 
which women need to consider (Bradbury et al., 2008; Cappelli et al., 1999; Leonarczyk and Mawn, 
2015; Underhill and Crotser, 2014).  Throughout all the articulation of patient concerns, the 
subsequent clinical and risk assessments and considerations for interventions, genetic counselling is 
an imperative step that is or should be offered to patients to help them navigate through all the 
scenarios they find themselves in (Ciarleglio et al., 2003; Skirton and Patch, 2002; Vig and Wang, 
2012). 
 
 Although the offer and availability of cancer risk reduction strategies, genetic 
testing, genetic counselling and surveillance and treatment services differs across Western societies 
as per the different health care systems, inequality trends in use of those services appears common 
(Mehta 2005, Allford et al. 2014, Daly & Olopade 2015). Among diverse patient populations, ethnic 
minority women, black women in particular, are visibly under-represented in who accesses the 
various cancer genetics services, including in uptake of interventions to reduce risk of developing 
breast and ovarian cancer (Armstrong et al. 2005, Mehta 2005, Salant et al. 2006, Halbert et al. 
2006, 2010, Kinney et al. 2006, Ellington et al. 2007, Bradbury et al. 2008, Allford et al. 2014, 
Robinson et al. 2015, Lynce et al. 2015, Underhill et al. 2016, Cragun et al. 2017, Jones et al. 2017). 
In general, various reasons have been offered for the reduced presence in cancer genetics services 
by women from ethnic minority groups and the subsequent inequalities in health outcomes resulting 
from the patterns of use of related services.  
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For instance, despite the availability of guidelines to help clinicians act on patient concerns, 
clinical assessments or referrals to specialist cancer genetics services, based on a person’s age, 
number of affected relatives and types of cancer for example (National Cancer Institute, 2015; 
National Institute for Health and Care Excellence, 2013), for various reasons, the use of those 
guidelines is varied. It has been reported in some cases that clinicians have limited knowledge of the 
relevant cancer referral pathways or of cancer genetics itself (Watson et al., 2002) which affect the 
timing, quality and effectiveness of their clinical assessments and subsequent decisions. Additionally, 
Daly and Olopade (2015) highlight that in other cases, even when clinical assessments have been 
considered, delays in referrals and poor follow-up patterns compound the issue of inequalities in 
uptake and use of cancer genetics services. Other reasons affecting use of cancer genetics services 
discussed in the literature include, but are not limited to, medical mistrust, and worries about 
confidentiality and discrimination (Singer et al. 2004, Kinney et al. 2006, Sheppard et al. 2013, Jones 
et al. 2017), lack of knowledge or awareness about services (Halbert et al., 2005; Hann et al., 2017; 
Jones et al., 2017; Sheppard et al., 2014) and insurance concerns or payment for services (Catz et al., 
2005; Sheppard et al., 2014; Singer et al., 2004).  
 
When barriers such as insurance and payments to cover costs for treatment; or lack of 
education and awareness have been addressed, the patterns of use among ethnic minority groups 
have remained largely unchanged. The trends of reduced service use become even more noticeable 
post genetic counselling and testing where women from Black and Minority Ethnic (BME) groups are 
reported in some research as not taking up risk reduction at similar rates to Caucasian counterparts 
(Kinney et al. 2006, Susswein et al. 2008, Pagán et al. 2009, Saulsberry & Terry 2013). In BME 
women, there appears to be a stronger preference for surveillance such as through MRI, ultrasounds 
and breast self-assessment over surgical options, even when those preferences are not always 
adhered to or as effective in detecting early disease (Kinney et al. 2006, Bradbury et al. 2008, Lynce 
et al. 2015, Cragun et al. 2017). Although some information can be found about reasons people 
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undertake or forgo risk reduction (Bradbury et al., 2008; Cragun et al., 2017; Grimmer et al., 2015; 
Klitzman and Chung, 2010), for countries such as the UK where issues of insurance and payment 
structures are generally not as pertinent as they may be in the USA, there is little information about 
those decision-making processes by BME women. This article thus adds to the growing literature 
exploring why such trends of under-use of certain genetics services exist and focusses particularly on 
how women from BME backgrounds make decisions for risk reduction strategies. The results provide 
a different perspective towards health service use, suggesting that women who have had breast 
and/or ovarian cancer and genetic testing hold diverse reasons for choosing, preferring or rejecting 
risk reduction interventions.  
 
Aim 
 Taken from a broader research project discussing women’s perspectives and knowledge of 
familial cancers, the aim of this article is to present qualitative findings about how a group of 
patients use that knowledge and understanding to navigate concerns and decisions around risk 
reduction strategies. While previous discussions and interventions to encourage use of cancer 
genetic services among minority groups have overwhelmingly focussed on the role of awareness and 
knowledge of genetic cancers as discussed by Armstrong et al.  (2005), Kinney et al. (2006), Brewster 
et al. (2007) and Underhill et al. (2016); when it comes to decisions around risk reduction, various 
studies attest to the complex processes of evaluations and decision-making that are inherent in 
discussions and decisions for participating in those interventions (Bradbury et al., 2008; Daly and 
Olopade, 2015; Klitzman and Chung, 2010). It is towards this complex knowledge that this article 
aims to add. The evidence presented here will be drawn from a qualitative study of a group of 
women who underwent genetic testing following cancer diagnoses and will explore their 
perspectives and concerns towards risk reduction strategies.  
 
Methodology, theoretical underpinning and participants 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 6
 Understanding patients’ perspectives and concerns enables practitioners and researchers to 
better explain and work with those patients’ in decision-making processes. Context is thus an 
important factor for any health decision that people make, as no decisions or actions are undertaken 
in isolation (Calnan, 1987; Geertz, 1973; Heath, 2013).  Busby et al. (1997) discuss the concept that 
there exist bodies of knowledge, where contexts and various sources of information are brought 
together to make sense of scientific concepts, thus creating lay perspectives which are useful to 
inform action and decisions.  A similar approach to use of contexts and understanding process was 
applied in the broader research study, where the theoretical underpinnings of social construction 
(Berger and Luckmann, 1966) and symbolic interaction (Blumer, 1986) provided a philosophical lens 
with which to view the decision-making processes for the particular cohort of BME women under 
discussion.  Social construction is premised on the idea that people’s understanding and knowledge 
of an object or concept are shaped by how they make use of that concept, with meanings and 
realities ‘constructed’ by those within that social group. This means that meanings and perspectives 
are likely to differ from group to group, as what influences social meanings will also differ. There is 
no one correct or fixed meaning of a concept because the different interactions with it by different 
people, create new and diverse meanings upon that object or concept. Social construction is notable 
in how people use words and language to communicate the meaning they hold and can thus make 
claims about the way the world is or their experiences of it (Berger and Luckmann, 1966; Gergen, 
2010, 1999a; Hacking, 1999).  
 
The second theory of symbolic interaction privileges the creation of meaning through 
people’s interactions with others around a concept or object. The meanings that individuals create 
are constantly changing based on their contact with an object, but additionally, their evaluation of 
others’ behaviours towards the same object (Blumer, 1986; Carter and Fuller, 2015; Denzin, 1992; 
Pascale, 2011). By interpreting other people’s behaviours and actions, the individual can form a 
perspective, understanding and opinion about what something means and in turn, how they might 
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modify their behaviour in line with any new interpretation they make. Together, theories of social 
construction and symbolic interaction argue for an interpretive way of investigating meaning, one 
that acknowledges that objects and concepts are likely to bring different truths and different 
perspectives for diverse societies. To make full use of the theories within the over-arching study 
from which this discussion arises, a constructivist grounded theory approach (Charmaz, 2017, 2008, 
2006) was used, where knowledge reported is understood to be contextual and time-bound, and is 
potentially a version of the general perspectives some BME women hold, which they share with the 
researcher through interviews.  Acknowledging the fluid nature of knowledge means one gains an 
insight into others’ minds, insights which are highly useful for future interrogations into the multiple 
or main factors and complex ways in which those factors are brought together to make sense of 
scientific and medical concepts and related clinical concerns (Busby et al., 1997; Calnan, 1987; 
Lipworth et al., 2010; Walter et al., 2004).  
 
The focus of the article are results reported from a sub-group of 10 women who had 
undergone genetic testing, out of the 15 women who had participated in the bigger qualitative 
study. Participants for the overall qualitative study were recruited from a tertiary hospital in the 
South of England. The hospital provided a range of cancer genetics services in a wide range of 
settings, including community and satellite clinics, in addition to routine hospital-based care and 
services. Coverage of sites was predominantly within London and the South East of England. 
Participants had in the past been clinically assessed for personal and family histories, which included 
breast, ovarian, lung and prostate cancers. As such, women who had attended any of the clinical 
cancer services between 2013 and 2016 were eligible for participation in the study with further 
eligibility based on documented ethnic group affiliation. The study dates coincided with the 
publication of the latest clinical care guidelines on familial cancers (National Institute for Health and 
Care Excellence, 2013) and when the bigger qualitative study commenced. Invitations to participate 
were sent out by letter, with those interested responding as appropriate.  
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Despite the documented ethnic groups, women in the study were asked to self-describe, as 
an acknowledgement that ethnicity was a subjective concept whose membership carried different 
meanings (Bhopal, 2004; Jones, 2008; Sheldon and Parker, 1992). We acknowledge, however, that 
our use of the term BME is itself contentious but chosen as a working albeit inadequate descriptor 
between the potentially different and subjective ways in which people define themselves or are 
defined by others. Despite this use aligning with discussions in some policy and research documents 
(Baker, 2013; Jacobs et al., 2007; Thompson and Van Der Molen, 2009), other terms such as Black, 
Asian and Minority Ethnic (BAME) or ethnic minority have also been used in research and 
questioned by others (Okolosie et al., 2016). 
 
Nonetheless, the women broadly self-identified as coming from South Asian, Black African 
and Black Caribbean backgrounds, although what each of those categories meant was noted to be 
fluid and heterogeneous (Table 1). Of the 10 women, who all were the first to be tested in their 
families, 6 had returned positive BRCA mutation results, while the remaining had 
uninformative/negative/inconclusive results (Table 1).  
 
 
 
 
Participant and 
age 
Ethnicity Place of birth Cancer history BRCA1/2 
mutation 
history 
P1, 40s Black 
African/British 
Nigeria Breast cancer, no 
family history 
Positive 
P2, 30s Black 
African/French 
Congo Breast cancer, 
family history of 
breast cancer 
Positive 
P3, 30s Black British UK Breast cancer Positive 
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and family 
history 
P4, 60s Black Caribbean Jamaica Breast cancer, 
family history of 
prostate 
Inconclusive 
P5, 50s Black African Congo Breast cancer, 
Family history of 
breast and 
ovarian cancer 
Positive 
P6, 50s British/Pakistani UK Breast cancer, 
family history of 
breast cancer 
Positive 
P7, 40s British/Indian Africa Breast cancer Positive 
P8, 40s Black British UK Breast cancer, 
sarcoma, lung 
cancer, family 
history of cancer 
Inconclusive 
P9, 50s Black African Africa Breast cancer Inconclusive 
P10, 50s British/Indian Africa Breast cancer Inconclusive 
Table 1 – Participant details (NB Participants numbered by their entry into the study)  
 
Finally, relevant research and ethical approvals as well as individual informed consent had 
been sought and obtained prior to participation. Each participant was interviewed once and all 
agreed to have their interviews audio-recorded, each lasting between 60-150 minutes. Data was 
stored in a de-identified way, on a password-protected computer, with de-identified transcripts 
uploaded onto a computer software programme, Nvivo, for data management and analysis. Analysis 
was conducted manually and in line with grounded theory methodology. While data analyses were 
conducted using line-by-line coding techniques of grounded theory (Charmaz, 2006; Saldaña, 2009), 
the results presented here emerge from part thematic analysis (Braun and Clarke, 2006) and part 
grounded theory analytic processes, since the objectives of this article were not themselves the 
main objectives of the main qualitative study. Results are presented in a descriptive manner, with 
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participants’ quotations provided verbatim to highlight the themes under discussion (Sandelowski, 
1994). 
 
 Results 
To understand how these participants interacted with genetics-related health services, it is 
important that the various influences and ways to interact with and evaluate genetics as a scientific 
concept be explored in more detail. In line with the theoretical underpinnings of symbolic 
interaction and social construction, results show that the knowledge and meaning of genetic cancers 
that underpinned and guided women’s ideas around risk reduction strategies, were created out of 
various individual medical and social concerns and interactions with cancer.  Social and medical 
situations created functional and contextual knowledge and understanding of genetic cancers that 
helped our participants decide for or against certain risk reduction strategies. Functional knowledge 
was a constructed knowledge that one could draw upon through lived experiences of the disease 
and which itself took into consideration the entirety of one’s personal, social and medical life. The 
context that influenced one’s final decision towards risk reduction was a mix of historical and 
current medical practices and outcomes which enabled the participants to navigate the options on 
offer and their own personal understanding and concerns of familial or inherited cancers (Figure 1). 
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Figure 1 - Interactions leading to cancer genetics decisions 
  
 
As such, this cohort of women ascribed social meanings to scientific and medical concepts 
and based those social meanings on prior experiences and interactions with family. The knowledge 
that the participants used to underpin their decision-making processes was thereby constructed 
from various evaluations of science, experiences of health as well as to what extent medical genetics 
explained women’s and their families’ disease histories (Figure 2).  Within their evaluations, 
scientific knowledge emerged as a knowledge filled with flaws and uncertainties, which in turn 
created multiple reasons for individuals to accept, decline or even prefer risk reduction strategies 
when at times that offer was not available to them. In the end, making decisions about risk 
reduction was not only about accepting knowledge that surgeries would aim to reduce one’s risk, 
but finding a way in which that medical knowledge would fit with one’s wider personal expectations 
and one’s personal ideas about familial and inherited cancers.  
•Perspectives to view 
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Figure 2 - Knowledge base for decision-making 
Varied perspectives were formed as the participants grappled with what they presumed was the 
interface between medical knowledge and their own and significant others’ health experiences. As 
medicine and science were not stand-alone entities or sources of information, any related 
medical/scientific knowledge was related to previously held meanings of the concepts, but meanings 
created in different bio-social circumstances. Medical knowledge was imported from those previous 
circumstances and used in diverse and imaginative ways, to account for past or preferred decisions 
for risk reduction.  
 
“When they said to me it's in the beginning and we gonna remove the cancer you so far 
have, you gonna keep your breast. And I spoke to my sister in France, she said to me: ‘get 
rid of your breast.’ Yea, because I know that many woman got ovarian cancer or breast 
cancer and when it spread on you, you can die. So I decide that because I got big fibroid in 
EVALUATING KNOWLEDGE OF SCIENCE, 
MEDICINE AND CANCER
Perspectives and 
meaning 
Personal medical 
knowledge
Shared family 
knowledge
Personal and 
family health 
experiences
Experiencing 
genetics
Family perspectives
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Experiences
Uncertainty and 
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my womb, I want them to remove it, I don't want to keep it anymore - I don't want to get 
cancer that way.” (P8, BRCA Positive, aged 50s) 
 
Not only was the above participant’s medical knowledge based on her own understanding of risk 
factors for future disease, she also sought medical opinion from family. Medical knowledge became 
a symbolic object that was shared and passed around for others to think on, provide opinion and 
return for a final social meaning. That this same participant had already had breast cancer, with a 
significant family history, meant that she perceived fibroids as something with more medical 
meaning in her life, on which she prescribed risk for developing further cancers. Her personalised 
and social understanding thereby meant she symbolised her fibroid as a risk that had to be removed.  
 
It is worth noting that even if some of the participants had returned mutation negative results, that 
is a known pathogenic mutation was not identified, this did not stop them from wishing the offer for 
risk reduction surgeries for instance had been made to them. The excerpt below shows how the 
symbolic meanings ascribed to fibroids are also ascribed to other medical factors in new ways and 
used to give more intensive clinical assessments. 
 
“I was prepared to have my ovaries removed, because yes, not only because of the 
oestrogen production but breast and ovarian are all linked apparently. So I, personally I 
have nothing to lose if I had to have my ovaries removed.” (P14, BRCA Neg, 50s) 
 
Similar to P8 above, this participant, P14, also used her own medical understanding of risk factors to 
explain how she would have been willing to undergo surgery to reduce what she saw as a significant 
risk.  Also, having undergone treatment for a previous breast cancer, this participant used various 
sources of medical knowledge, and infused them with her own health experiences thus reducing the 
role of mutation testing and her negative result in her decision-making. She later conceded, in a 
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different point in her interview, that the result she received for her test results had not meant much 
to her, as there was always a chance that future technologies would provide a genetic link to the 
cancers recorded in her family – a chance for which a current decision to undergo surgery would be 
justified.  
 
Uncertainty was a common theme among different participants, where scepticism and uncertainty 
surrounding the non-deterministic relationship between having a mutation and developing cancer 
was a considered factor in scientific evaluations and related medical decisions. Some participants, 
for instance, displayed their scepticism and justified delaying risk reduction surgeries based on their 
family histories of disease progression post surgeries. Despite being mutation positive, the meaning 
given to the mutation was less influential than what their loved ones had gone through. This 
weighing of pasts and futures at times negated one’s personal evaluated risk and medical risk and 
gave weighting to family experiences instead. As noted by the next participant, decision-making was 
a thought-out and personally rationalised process. 
 
“Yes, because even you have the gene, it doesn't mean that you can get sick. […] I saw 
women like my mum having her breast removed. But the cancer came back in the same 
place. So for me, it's not the first choice. If nothing happens, don't do anything. It's my 
point of view. […] it's not easy thing to do, you know?” (P4, Pos, 30s) 
 
One had to continually balance these competing influences of science, genetics results and health 
and disease experiences, something P4 noted was ‘not an easy thing to do’. 
 
For other participants, however, rationalising decisions meant going wider to the media portrayals 
of the impact of having a disease predisposing mutation, and evaluating instead the media messages 
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of risk reduction against the likely physical effects and what various parts of their body which might 
be affected meant to them. For this, breasts and ovaries did not hold similar importance to women, 
as shown next by P12 who says she would firmly base her surgical decisions on how she views her 
body and how those views would impact her psychological health. 
 
“I always said to myself, even if I've got the BRCA gene, I'm not gonna go and take my 
breasts off [….] not gonna be an Angelina Jolie… I will have to wait until the cancer 
happens. About my ovaries? Without a doubt, get rid of them. I don't need them. I'm not 
having a baby! That breast would affect your life. I know you don't physically use it for 
anything but it's there. And you can see the scars, you look in the mirror and you can see 
what's going on there.” (P12, Neg, 40s) 
 
By understanding how some women gave social meaning to their body parts and the subsequent 
values and uses they imbued on them, one can then start to see how the creation of meaning and 
symbolic values influences decision-making process. For instance, if something holds considerable 
value, then someone might be more likely to preserve that value than lose it. A case in point is 
participant P5 who initially seemed set on her decision for undergoing surgery as the most rational 
thing to do, having tested positive for a BRCA mutation in addition to her personal and family history 
of early onset breast cancers. Yet, when faced with changes in her social life, what mattered to her 
at that point stopped being about reducing risk, but delaying that decision until such a point where 
she had fully assessed her new childbearing circumstances and future plans: 
 
“My social circumstances is different. Do I actually want another child? […] I still want to 
have that choice. It would be far easier if, when I went to the assisted conception unit, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 16
they had said actually you haven't got any follicles left and you're starting menopause. 
Because I'd be like right. […] you just whip them out, the ovaries.”(P5, Pos, 30s) 
 
The possibility of wanting more children loomed larger and more urgent than current evaluations of 
future risk, which led to a change of mind about when and if to undergo further risk reduction 
interventions. As such, not all women in similar medical backgrounds made the same choices and 
instead were guided by social circumstances. As participant P9 indicated, quite similarly to P5, social 
meanings and circumstances were vital for decision-making. Even if the end point was similar to 
what medical practitioners might have advised, the reasons for P9’s decisions were not entirely for 
the same medical reasons. 
 
“And I thought well, I'm not gonna have any more kids, why am I going to worry about 
protection? Have the ovaries and tubes removed, don't want to get pregnant. That was 
done more for that really, rather than ... I know they called it preventative surgery coz 
they were preventing it. But me, I was preventing a pregnancy.” (P9, Pos, 40s) 
 
However, offered a mastectomy to remove her remaining breast that was not affected by breast 
cancer, the above participant had declined, believing that having that breast was more important to 
her as she equated it with the only ‘womanly thing’ she had left. For P9, feeling womanly appeared 
far more significant and important to her than her personal risk of future cancer, a sentiment voiced 
by P12 above.   
 
Despite these decisions impacting their personal health, as these BME women made considerations 
for their own health, they also thought about and provided advice to their kin, providing possible 
future layers of complex decision-making for those in their families who would be in similar 
predicaments, specifically their daughters. Asked what advice they would give to their children in 
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similar circumstances, once again, the participants portrayed a mix of personalised rationality based 
on varied evaluations and contextualisation of health and disease experiences in relation to scientific 
information.  
 
“I won't want them to go through that. So therefore I would say, while they are young and 
a lot of people with good health, they have false parts anyway, if it happens I would 
implant, I would ask them to go for implant. I would advise them.” (P15, Neg, 50s) 
 
“If you want a child, have your child. I don't care whether you married or not. Just have 
your child and then decide after that if you want to get your ovaries removed, breasts 
removed […] it's not the end of the world, there is formula milk now. Lots of children have 
been on formula and they are fine. So she can have RRS and there is lots of implants and 
things.” (P10, Pos, 40s) 
 
Discussion 
Making decisions for or against risk reduction strategies is shown as a complex endeavour.  
The decisions these women made were not easily traced or predicted, but had to be understood as 
decisions that were personally rational and guided by certain frames of thought. As Cragun et al. 
(2017) argue, ongoing differences between provision, management and use of cancer genetics 
services for and among ethnic minority women, increase inequalities in health outcomes, especially 
as there are high rates of variants of uncertain significance discovered in genetic testing, of almost 
four times the average rate, in Black women when compared to non-Jewish White women (Nanda et 
al., 2013; Pal et al., 2015). There are also more aggressive breast cancers and poor health outcomes 
in those groups already which increase the health disparities noted  (Daly and Olopade, 2015; Pal et 
al., 2015; Saulsberry and Terry, 2013; Seiler et al., 2017). As such, failure to cater to people’s diverse 
ways of thinking, compounds an expectation that patients must use only scientific knowledge of 
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genetics to make decisions which ignores the many reasons that might bring BME women into the 
genetics environment, and misses chances to find ways to improve their genetics related health 
outcomes.  
 
Finding ways to make the entirety of genetics services - not just screening, counselling and 
testing – more inclusive of diverse ways of interacting and knowing genetic cancers will provide new 
thinking towards ways to reduce current differences in cancer genetics services uptake and 
provision. While quantitative studies such as those by Schwartz et al. (2012) and van der Aa et al. 
(2015) for instance, are useful for making predictions by patient characteristics and histories of who 
might use risk reduction strategies, qualitative work similar to Salant et al. (2006) and Bradbury et al. 
(2008) enable a deeper understanding of some of the factors associated with the various decisions 
that those patients make, particularly in ethnic minority women. Exploring women’s concerns 
around cancers that may have an inherited component leads to several points of interest, some of 
which are explored here, which must be considered if health practitioners are going to successfully 
engage BME women at increased risk of cancers to consider risk reduction strategies over 
surveillance.   
 
Exploring what information is important, when it is important and why it is important to individuals 
as well as how it helps them understand and interact with a situation, are some of the most 
fundamental factors that health care providers must be attuned to when engaging in clinical 
consultations. The idea that individuals act rationally in decision-making begins to take on a new 
meaning, where rationality is about the best outcome in a certain context for that person. Within 
that, direct scientific knowledge may be inadequate as presented by medical practitioners, to assist 
patients in making what might be considered as rational decisions for risk reduction. Rationality is 
then acknowledged as itself not having universal meanings (Pescosolido, 1992), but contextual and 
individualised ones instead. Rationality becomes something differently experienced and evidenced 
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by those having to make those various health-related decisions and for the BME women reported in 
this article, their actions and evaluations are shown as rational to them.  Therefore, as shown in this 
article, in considering their influential factors that guide preferring, taking or rejecting interventions, 
patients act rationally as they weigh up the various bio-social effects of the strategies on offer.  The 
patients evaluate any perceived benefits and negative effects against medical opinion.  
 
The personal and family experiences of cancer and the meanings and values of science influence the 
scientific evaluations which our participants carry out. They then use those evaluations to 
understand scenarios and situations as shown above, processes which are highlighted in symbolic 
interactionist and social constructionist theories and are shown to underpin our participants’ 
decision-making. This means that, in the end, genetics investigations into service use must stop 
being about categorising health decisions by BME women as different to dominant populations, or 
being about lack of genetic knowledge, but about the process in which all knowledge is created and 
used, results similar to work by Hallowell et al., (2001) and Howard et al., (2011) which are arguably 
universal across disease and patient groups. Such a perspective is useful for translating previous 
literature on non-BME populations around their decisions for accepting or rejecting risk reduction, 
to BME women and finding common solutions to all ethnic groups. What Figure 1 and 2 show is that 
knowledge construction regarding familial cancers is not a strange process specific only to BME 
women, but can be noted in various clinical situations across all ethnicities. This is an important 
consideration since instances of such decision-making evaluations are noted in various literature, 
and should thus not aim to make BME women necessarily ‘other’ or different from non-BME 
women.   
 
Miller et al. (2010) for instance, in a general literature review, suggest that several reasons affecting 
uptake of interventions revolve around issues such as menopausal side-effects and one’s age when 
they have to consider such effects, similar considerations mentioned by some of the ethnic minority 
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participants under discussion. However, while Miller et al. (2010) go on to suggest that surgeries 
might be a way to reduce uncertainties, the BME women’s evaluations presented in this article 
regarding scientific uncertainty, which were juxtaposed with their family histories at times led to 
these women framing surgical interventions as something to be avoided. Despite that, if other 
concerns, such as being healthy for one’s family was more important, the uncertainties seen within 
these medical interventions in relation to family experiences would then at times be diminished, 
leading the participants to take up interventions. Incidentally, the article findings go against those in 
Miller et al. (2010)’s review where the suggestion was that for women with positive genetic 
mutations, strong family history of cancer might enhance one’s intent to undergo surgical 
interventions themselves since the BME participants above did not use family history as reason for 
deciding around risk reduction interventions.    
 
The meanings of genetic disease and associated risk must be understood to carry different 
levels of importance at different times in women’s lives. Decisions to undergo surgery can, as shown 
above, be delayed or diminished by thoughts around childbearing and breastfeeding, as well as what 
gives one their self-worth and identity. The various reasons that women have to consider are 
invariably a mix of clinician advice and experiences of cancers within the family, to name a few 
(Lifford et al., 2013).  In fact, Dew (2016) shows that decisions for health, and how people 
understand various health related concerns are played out in many locations, and not just the clinic, 
as shown by the narratives and reasons given by these women. As such, our participants, in deciding 
on risk reduction strategies, evaluate their concerns using information gathered from their clinical 
consultations but placed within the context of their homes and social environments. Such concerns 
for various aspects of one’s personal and social life - for instance feeling like a woman, wanting to 
breastfeed or starting a family – all merge with perspectives towards the gene for cancer and its 
place in future health management.   
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All these factors have been shown to create ways in which one shapes their interaction with 
health services (Bradbury et al., 2008; Crew, 2017; Hallowell et al., 2004; Skirton and Eiser, 2003) 
and should thus be part of the discussions clinicians will have with their patients from diverse ethnic 
groups.  The concept of genetics therefore has multiple meanings (Atkinson et al., 2013; 
Featherstone et al., 2006; Hallowell et al., 2004; Richards, 1996; Salant et al., 2006) which will each 
influence people’s perspectives towards how to interact with any related health maximising 
decisions and what advice they may give to family. Given the diversity of meanings that participants 
held about the same concept, the construction of knowledge shows that the sources of influence 
that patients use in determining their next course of action are also diverse but importantly, hold 
very deeply rooted and significant associations for their health and decision-making (Burr, 2015; 
Gergen, 1999b; Mellon et al., 2013; Saleh et al., 2012).  
 
Fields of interaction and diverse meanings given towards familial cancers can at times mean 
that some women might place higher concern on their family and personal histories than clinical 
evaluations might give, leading those who may not be eligible for risk reduction interventions to 
express an interest and willingness to undergo those interventions. This was shown earlier by 
women who had negative/uninformative/inconclusive results following BRCA testing who reported 
willingness to undergo surgery, had it been offered to them. These issues must be considered in the 
light of Black women specifically who are known to have high rates of results of unknown 
significance, or whose family members may not have had a chance for genetic testing if those family 
members live outside of Western countries. Thus, contexts in which health decisions are evaluated 
and made are key. Just as Willis et al. (2016) note, the importance of understanding sources of 
knowledge helps explain how patients navigate health systems.  As such, women’s contexts are 
highly influential to how they create their functional knowledge of familial disease. Additionally, and 
importantly, decisions over how to engage with risk reduction strategies and cancer genetics 
services are related to that functional knowledge that women hold. Navigating health systems is 
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therefore a matter of what knowledge one holds and privileges at specific times and how much 
negotiation can occur between them and their health providers.  
 
Bradbury et al. (2008) and Howard et al. (2009, 2010, 2011) have shown such a knowledge 
usage in action, by detailing some of the concerns influencing rejection or uptake of risk reduction 
strategies such as fear of death, wanting it to be the right time to decide against possibility that 
different options may arise in the future. Thus, although ethnic minority women remain under-
represented in interventions to reduce cancer risk, they are shown to hold similar routes to 
evaluations of concerns to those raised in studies by Hallowell et al. (2001), Meiser et al. (2003, 
Garcia et al. (2014), Rosenberg & Partridge (2015), Padamsee et al. (2017) and Padamsee et al. 
(2017). In the end, creating non-judgemental zones of interaction in clinical practice which enable 
women to fully explore the options available to them against the options they would prefer, will 
ensure that women from diverse backgrounds are supported and guided in their decision-making in 
ways that will consider all their factors of concern while providing the best chances for better health 
outcomes.   
 
Conclusion 
While the use of risk reduction interventions remains for some, a contentious strategy for 
managing cancer (Klitzman and Chung, 2010; Long Roche et al., 2017; Salant et al., 2006; 
Tschernichovsky and Goodman, 2017), BME women’s evaluations of the factors that lead them to 
request, reject or accept such interventions remain an area in which more information can be 
gathered.  Although a small study for which no generalisations to the wider population can be made 
explicitly, this article goes some way to provide extra information on the contexts and thoughts of a 
group of women who had undergone genetic testing and details the way the participants navigated 
discussions and decisions for reducing future risk of cancer. Results are interesting in their similarity 
to non-BME focused studies, suggesting that the systems and processes patients use to make 
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decisions are likely to be more similar than researchers and clinicians sometimes acknowledge. It is 
important to recognise that not all women rejected or accepted interventions outright, based on 
medical opinion alone, but that as Busby et al. (1997), Dew (2016) and Willis et al. (2016) have 
highlighted, women created specific and functional forms of social knowledge to help them make 
sense of their clinical situations and construct rational motives for their decisions around risk 
reduction strategies. Helping clinicians understand those rational motives will be useful in helping 
women engage deeper in discussions around future health maximising. More importantly, it will 
help identify how BME women might want to interact with genetics services and how those 
attending to those interactions will find ways to ensure when women make the decisions to request, 
accept or reject risk reduction, all the pertinent concerns, both medical and social are discussed and 
women can make the right choices for them, given their different ways of knowing familial cancers.  
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